This study has also shown that overexpression of WEE1 could sensitize GBM cells to be more tolerant to TMZ treatment, whereas depletion of WEE1 could sensitize TMZ-resistant cells to TMZ treatment. The gene discussed is WEE1; the disease is glioblastoma.